[Start off with smallpox vaccination. That should wean anyone off vaccination. You run the risk of brain damage, disease or death and your kid can still get the disease. Russian Roulette. As Harris Coulter said: "In truth, the benefits accrue to the physician, while the patient runs the risks."— (Divided Legacy Vol 3). Even the vaccinators admitted one of their Mumps vaccines was completely useless, and you can see how a Mumps vaccine is dangerous with MMR Urabe. Most kids who get one of the vaccine diseases are vaccinated.]Quotes
Quian JW.An outbreak of varicella despite vaccination.
N Engl J Med. 2003 Apr 3;348(14):1405-7; author reply 1405-7. No abstract
available. PMID: 12678027 [PubMed - indexed for
Wack RP. An outbreak of varicella despite vaccination. N Engl J Med. 2003 Apr 3;348(14):1405-7; author reply 1405-7. No abstract available. PMID: 12678025 [PubMed - indexed for MEDLINE]
Giusti RJ.An outbreak of varicella despite vaccination. N Engl J Med. 2003 Apr 3;348(14):1405-7; author reply 1405-7. No abstract available. PMID: 12672872 [PubMed - indexed for MEDLINE]
Manghani DK, et al. Pleomorphism of fine structure of rabies virus in
human and experimental brain. J Neurol Sci. 1986 Sep;75(2):181-93. PMID: 3760910; UI:
Identification of the Negri bodies in the brain of an 8-year-old boy who died 8 days after a paralytic illness and 20 days after a dog bite, and who had received 9 injections of Semple's anti-rabies vaccine, provided evidence that he died of acute rabies encephalitis and not of post-vaccinal allergic encephalomyelitis. The Negri bodies in the human subject and those seen in the inoculated mouse differed in their morphological structure: the former consisted of a matrix of very fine granular material bearing larger granules or strands of higher electron-density resembling nucleic acids and representing products of host cell-virus interaction; and the latter showed better defined areas of granular matrix containing tubular, bullet-shaped and elongated forms of viral structures, and nucleocapsids or capsule-deficient cores, representing the virions, emerging from them. Fine structural examination of the patient's brain and of the inoculated mouse has provided evidence of the pleomorphism of the Negri bodies and the various stages of formation of viral material and virions in them, the animal alone showing the mature virions of rabies, and proving the infectivity of the Negri bodies of the human brain. (Emphasis added)
"Reemergence of invasive haemophilus influenzae type b disease in a well-vaccinated population on remote Alaska" (Journal of Infectious Diseases, vol. 179, no. 1, January 1999, pp. 101-106, reported via Vaccine Weekly, NewsEdge Corporation news release, February 12, 1999): In 1996, after administration of Hib conjugate vaccine (DTP whole-cell vaccine + Hib), cases ofinvasive Hib disease, as well as "silent" Hib infections, increased.
"High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)," Acta Paediatrica Japonica, vol. 39, no. 6, December 1997, pp. 663-8: the rate of varicella [chicken pox] occurrence among vaccinees was found to be much higher than rates reported previously by other authors. "Varicella vaccine seems to be effective in modifying the symptoms of varicella, but not potent enough in protecting from VZV infection."
"The characteristics of poliovirus strains circulating in Ukraine in 1982-1994" (Mikrobiol[ogie] Z. vol. 60, no. 2, March-April 1998, pp. 44-49 [article in Russian]): "The long-term use of the live poliomyelitis vaccine has not stopped circulation of virulent polioviruses."
"Is smallpox history?" (The Lancet, vol. 353, no. 9164, May 8, 1999): "A pilgrim returned home to Yugoslavia from Mecca in February, 1972, with a fever In the 4 weeks since the pilgrim first had his fever, 150 people were infected across the country. It took 4 weeks before doctors, nurses, and health authorities knew they were dealing with smallpox 175 people contracted smallpox [thereafter] and 35 died these events occurred in a well-vaccinated population."
"Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination" (Scandinavian Journal of Infectious Disease vol. 29, no. 2, 1997, pp.187-90): Two, five, seven and twelve years after vaccination with further attenuated live measles vaccine, three of five patients experienced modified measles infection, and the remaining two had typical measles. "This may be the first SVF case report that confirms the existence of completely waning immunity in recipients of the further attenuated live measles vaccines."
"H[epatitis] B V[irus] prevalence is unchanged by hepatitis B [vaccine]," report by Michael Belkin, statistician, based on nationwide sampling of the prevalence of hepatitis B by the Centers for Disease Control, 1988, to 1994, for comparison with figures from 1976 to 1980 [American Journal of Public Health, vol. 89, no. 14, 1999]: "There was an age-adjusted prevalence of 5.5% in the first study and 4.9% in the second; these differences are not statistically significant. The authors concluded that the widespread use of HBV vaccine in the 1980s has not had a major impact on the overall prevalence of this infection (communication posted on the Vaccine Information and Awareness (VIA) listserv [firstname.lastname@example.org], March 11, 1999, 12:22 p.m.).
Statistics:The efficacy of common vaccines may be greatly exaggerated. In a 1998 study, it was stated that "investigator bias probably has overestimated the efficacy of most vaccines." Clinicians' compliance levels in monitoring illness in vaccine recipients varied widely in trial protocols. "Less compliant investigators were far more likely to report data making vaccines appear more effective against mild or moderate disease. Our data suggest that observer compliance (observer bias) can significantly inflate calculated vaccine efficacy it is likely that all recently completed efficacy trials have been affected by this type of observer bias and all vaccines have considerably less efficacy against mild disease than published data suggest" (Pediatrics, vol. 102, no. 4, part 1, October 1998, pp. 909-912, reported as news release, "Clinical Trials; Vaccine Efficacy Overestimated ," posted December 2 to Vaccine Information and Awareness electronic mail discussion list [email@example.com], 9:42 a.m.).
AL, Johnson TR, Dagartzikas MI, Tobias JD. Endocarditis Attributable to
Group A beta-Hemolytic Streptococcus After Uncomplicated Varicella in a Vaccinated Child.
Pediatrics. 2000 Sep;106(3):E40. [Record as supplied by publisher] PMID: 10969124